Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
RO4929097
Description:
RO4929097 is a small-molecule gamma-secretase inhibitor studied for its effects on Notch signaling and cancer.
Related topics:
Glioma Diagnosis and Treatment (15%),
Developmental Biology and Gene Regulation (7%)
Wikidata ID:
wiki/Q27088591
OpenAlex ID:
keywords/ro4929097
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
2012
·
Anthony W. Tolcher
, Wells A. Messersmith
, et al.
·
Journal of Clinical Oncology
·
292
PDF
Preclinical Profile of a Potent γ-Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
2009
·
Leopoldo Luistro
, Wei He
, et al.
·
Cancer Research
·
204
A phase II study of RO4929097 in metastatic colorectal cancer
2012
·
Jonathan R. Strosberg
, Timothy Yeatman
, et al.
·
European Journal of Cancer
·
152
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
2016
·
Ran Xu
, Fumiko Shimizu
, et al.
·
Clinical Cancer Research
·
128
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
2014
·
Ana De Jesus-Acosta
, Daniel Laheru
, et al.
·
Investigational New Drugs
·
115
PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro
2019
·
Yunxia Wang
, Yijue Zhong
, et al.
·
Ecotoxicology and Environmental Safety
·
94
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
2015
·
Ivan Diaz-Padilla
, Michelle K. Wilson
, et al.
·
Gynecologic Oncology
·
88
NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma
2016
·
Sanaz Yahyanejad
, Henry King
, et al.
·
Oncotarget
·
86
PDF
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
2013
·
Suzanne Richter
, Philippe L. Bedard
, et al.
·
Investigational New Drugs
·
85
PDF
A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
2013
·
S Sahebjam
, P L Bedard
, et al.
·
British Journal of Cancer
·
78
PDF
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
2011
·
Chanh Huynh
, Laura Poliseno
, et al.
·
PLoS ONE
·
76
PDF
Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116
2018
·
Egle Kukcinaviciute
, Violeta Jonusiene
, et al.
·
Journal of Cellular Biochemistry
·
75
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
2012
·
Bisrat G. Debeb
, Evan N. Cohen
, et al.
·
Breast Cancer Research and Treatment
·
72
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer
2017
·
Dong Wang
, Jiahui Xu
, et al.
·
Cell Death and Differentiation
·
61
PDF
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
2013
·
Ivan Diaz-Padilla
, Hal Hirte
, et al.
·
Investigational New Drugs
·
59
PDF
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
2013
·
Lotte Hiddingh
, Bakhos A. Tannous
, et al.
·
Oncotarget
·
58
PDF
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ‐secretase inhibitor, RO4929097
2011
·
Wei He
, Leopoldo Luistro
, et al.
·
Molecular Oncology
·
54
PDF
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
2016
·
Edward Pan
, Jeffrey G. Supko
, et al.
·
Journal of Neuro-Oncology
·
53
Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts
2020
·
Christopher W. Wasson
, Rebecca L. Ross
, et al.
·
Arthritis Research & Therapy
·
52
PDF
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
2022
·
Mrinal M. Gounder
, Evan Rosenbaum
, et al.
·
Clinical Cancer Research
·
51
PDF
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors
2014
·
Noelle K. LoConte
, Albiruni R. A. Razak
, et al.
·
Investigational New Drugs
·
45
Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway
2017
·
Chun-Wu Tung
, Yung-Chien Hsu
, et al.
·
Scientific Reports
·
42
PDF
Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells
2014
·
Aleksandra Filipović
, Ylenia Lombardo
, et al.
·
Breast Cancer Research and Treatment
·
42
PDF
PTEN regulates sensitivity of melanoma cells to RO4929097, the γ-secretase inhibitor.
2013
·
Jayasree S Nair
, Tahir Sheikh
, et al.
·
PubMed
·
42
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)
2021
·
Julie A. Means-Powell
, Ingrid A. Mayer
, et al.
·
Clinical Breast Cancer
·
40
PDF
Show more works
View as search
Works count:
111
Citation count:
2,836
Year
Topic
Type